期刊文献+

放松疗法对绝经期高血压前期患者睡眠质量的影响 被引量:2

Effect of relaxation therapy on quality of sleep in patients with postmenopausal prehypertension
原文传递
导出
摘要 目的:提高绝经期高血压前期患者的睡眠质量,降低高血压发病率。方法:选择体检后诊断为高血压前期合并睡眠质量差(PSQI=14.34±0.77)的绝经期妇女32例,运用多种放松疗法进行干预。结果:经过为期1年的放松训练,PQ-SI总得分为(11.02±1.00)分;睡眠质量各因子得分均优于干预前,24 h动态血压监测(ABPM)值为(91.25±6.48/85.78±6.24)mmHg,与干预前相比有明显统计学差异(P<0.05)。结论:放松疗法有助于改善绝经期高血压前期患者的睡眠质量,使血压转归至正常,从而降低高血压发病率。 Objective: To improve the quality of sleep in patients with postmenopausal prehypertension, and reduce the morbidity of hypertension. Methods: Thirty - two postmenopausal women who were diagnosed as prehypertension combined with poor quality of sleep ( PSQI = 14. 34 ±0. 77) after, physical examination were selected and intervened with various relaxation therapies. Results: After relaxation therapy for one year, the total score of PQSI was ( 11.02 ± 1.00) ; the scores of various factors about quality of sleep were superior to those before intervention, 24 -hour dynamic ambulatory blood pressure monitoring (ABPM) value was (91.25± 6.48/85.78 ± 6. 24) mmHg, compared with before intervention, there was statistically significant difference ( P 〈 0. 05 ) . Conclusion: Relaxation therapy is helpful to improve quality of sleep in patients with postmenopausal prehypertension, reverse blood pressure to normal level, and reduce morbidity of hy- pertension.
出处 《中国妇幼保健》 CAS 北大核心 2012年第35期5738-5739,共2页 Maternal and Child Health Care of China
基金 唐山市2011年科学技术研究与发展指导计划(第一批)项目〔111302022a〕
关键词 放松疗法 绝经期 高血压前期 睡眠质量 Relaxation therapy Menopause Prehypertension Quality of sleep
  • 相关文献

参考文献5

二级参考文献30

  • 1[1]Lobo RA.Cardiovascular disease in women:Influence of hormonal replacement therapy.In:Safar M,Zanchetti A,eds.Hypertension in postmenopausal women[M].Germany,Springer-Verlag Berlin Heidelberg,1994,27-44.
  • 2[2]Gerhard M,Ganz P.How do we explain the clinical benefits of estrogen[J]? Circulation,1995,92:5-9.
  • 3[3]Burt VL,Whelton P,Roccella EJ,et al.Prevalence of hypertension in the US adult population.Results from the Third National Health and Nutrition Examination Survey,1988-1991[J].Hypertension,1995,25:305-313.
  • 4[4]Staessen J,Bulpitt CJ,Fagard K,et al.The influence of menopause on blood pressure[J].J Human Hypertension,1989,3:427-433.
  • 5[5]Matthews KA,Meilahn E,Kuller LH,et al.Menopause and risk factors for coronary heart disease[J].N Engl J Med,1989,321:641-646.
  • 6[6]Van Berensteyn EC,Vanthof MA,De Waard H.Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women:A mixed longitudinal study[J].Am J Epidemiol,1989,129:947-955.
  • 7[7]Corsini A,Bernini F,Quarato P,et al.Non-lipid-related effects of 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors[J].Cardiology,1996,87(6):458.
  • 8[8]Gilla CG,Zhou G,Matsubara L,et al.Collagen metabolism in cultured adult rat fibroblasts:response to angiotensin Ⅱ and aldostrone[J].J Mol Cell Cardiol,1994,26:809-820.
  • 9[9]Weber KT,Brilla CG.Pathological hypertrophy and cardiac interstitium.Fibrosis and renin-angiotensin-aldosterone system[J].Circulation,1991,83:1849-65.
  • 10[10]Su S,Hsiao C,Chu C,et al.Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension[J].Am J Cardiol,2000,86(5):514-8.

共引文献4148

同被引文献18

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部